| Literature DB >> 30542589 |
Peng Wang1, Fang Zhou1, Cheng Zhang1, Sheng-Yan Yin1, Lili Teng1, Lanlan Chen1, Xiao-Xiao Hu1, Hong-Wen Liu1, Xia Yin1, Xiao-Bing Zhang1.
Abstract
The complex environment of living organisms significantly challenges the selectivity of classic small-molecule fluorescent probes for bioimaging. Due to their predesigned topological structure and engineered internal pore surface, covalent organic frameworks (COFs) have the ability to filter out coexisting interference components and help to achieve accurate biosensing. Herein, we propose an effective interference-resistant strategy by creating a COF-based hybrid probe that combines the respective advantages of COFs and small-molecule probes. As a proof of concept, a two-photon fluorescent COF nanoprobe, namely TpASH-NPHS, is developed for targeting hydrogen sulfide (H2S) as a model analyte. TpASH-NPHS exhibits limited cytotoxicity, excellent photostability and long-term bioimaging capability. More importantly, compared with the small-molecule probe, TpASH-NPHS achieves accurate detection without the interference from intracellular enzymes. This allows us to monitor the levels of endogenous H2S in a mouse model of cirrhosis.Entities:
Year: 2018 PMID: 30542589 PMCID: PMC6243647 DOI: 10.1039/c8sc03393e
Source DB: PubMed Journal: Chem Sci ISSN: 2041-6520 Impact factor: 9.825
Fig. 1Construction and characterization of the two-photon fluorescent covalent organic framework nanoprobe TpASH-NPHS. (A) Synthesis of TpASH and its sequential post-synthesis modification. (B) TEM and (C) SEM images of TpASH, TpASH-Glc and TpASH-NPHS. (D) FTIR spectra of TpASH after sequential post-synthesis modification. (E) AFM image of the COF nanoprobe TpASH-NPHS. Inset: the image of the Tyndall effect of the TpASH-NPHS suspension (left: TpASH-NPHS and right: water; source of laser light on the left). (F) The size distribution of the COF nanoprobe TpASH-NPHS by DLS.
Fig. 2Interference-resistant fluorescence sensing of the COF nanoprobe TpASH-NPHS. (A) Constitution and mode of action of the COF-based nanoprobe TpASH-NPHS. (B) The fluorescence emission spectra of TpASH-NPHS in the presence of different concentrations of NaHS. (C) Linear response at low NaHS concentrations, R2 = 0.998. The standard curve of the TpASH-NPHS response to NaHS is y = 119 908.37448 + 17 831.54373x. λex = 440 nm. (D) Fluorescence response of TpASH-NPHS to various substances under normoxic (21% O2) and hypoxic (<0.1% O2) conditions. (E) The comparison of fluorescence response between TpASH-NPHS and CNPHS to different concentrations of HepG2 cell lysates under hypoxia.
Fig. 3Interference-resistant imaging of the COF nanoprobe TpASH-NPHS in live cells. (A) Two-photon confocal fluorescence imaging of TpASH-NPHS in HepG2 and HeLa cells. Scale bar: 20 μm. (B) Confocal fluorescence imaging of CNPHS or TpASH-NPHS in HepG2 cells under hypoxic conditions without or with the addition of exogenous H2S. Scale bar: 20 μm. (C) The relative pixel fluorescence intensity of HepG2 cell images. The pixel intensity from TpASH-NPHS incubated with H2S in HepG2 cells under normoxic conditions is defined as 1.0.
Fig. 4Interference-resistant two-photon fluorescence imaging of the COF nanoprobe TpASH-NPHS in deep tumor tissues. (A) Two-photon confocal fluorescence images of TpASH-NPHS and CNPHS under hypoxia in HepG2 tumor tissues without or with the addition of exogenous H2S. Scale bar: 300 μm. (B) The relative pixel fluorescence intensity of HepG2 tumor tissues. The pixel signal intensity from TpASH-NPHS incubated with H2S in HepG2 tumor tissues under normoxic conditions is defined as 1.0.
Fig. 5Monitoring of endogenous H2S in a cirrhotic liver model. (A) The liver cirrhosis mouse model was induced by subcutaneous injection of 40% CCl4. The liver tissue slices were harvested at different CCl4-treated periods. (B) Two-photon confocal fluorescence images of TpASH-NPHS in liver tissues of the cirrhotic mouse model at different CCl4-treated periods. Scale bar: 300 μm. (C) The enzyme activity of ALT and AST in mice serum. (D) Quantification of CSE levels in normal and liver cirrhosis models by ELISA.